Fifth Third Bancorp’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Fifth Third Bancorp’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-37,273	Closed	-$669K	–	2488
2017 Q4	$669K	Sell	37,273 -4,479	-11%	-$55.1K	﹤0.01%	591
2017 Q3	$493K	Sell	41,752 -769	-2%	-$8.63K	﹤0.01%	675
2017 Q2	$446K	Sell	42,521 -6,085	-13%	-$62K	﹤0.01%	718
2017 Q1	$535K	Buy	48,606 +6,903	+17%	+$80.1K	﹤0.01%	686
2016 Q4	$565K	Buy	+41,703	New	+$582K	﹤0.01%	687

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Fifth Third Bancorp's SCMP Position: Q1 2018 in Review

Fifth Third Bancorp sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 37,273 shares — an estimated $669K sold.

Fifth Third Bancorp first reported a position in SCMP in Q4 2016 and held it in 5 quarters. The position peaked at $669K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

Fifth Third Bancorp reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Fifth Third Bancorp sold 37,273 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $669K.
Fifth Third Bancorp first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2016 and held it in 5 quarters.
Fifth Third Bancorp's Sucampo Pharmaceuticals, Inc. position peaked at $669K in Q4 2017.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Fifth Third Bancorp's 13F filing for Q1 2018, filed 15 May 2018.